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Screening for cardiovascular 
risk in patients with anorexia 
nervosa
In young people, especially females, a high importance is placed on body image and physical appearance. Unfortunately, misperceptions of the ideal body shape 
and weight can encourage a pre-occupation with weight 
loss strategies. Long-term, these strategies may lead to ill-
health due to inadequate caloric intake, use of 
pharmacological agents, and extreme weight control 
methods such as fasting and excessive exercise (Shisslak et 
al, 1995; Reinking and Alexander, 2005; Petrie et al, 2009) 
potentially leading to eating disorders such as anorexia 
nervosa. The following review focuses on appropriate 
screening techniques for identifying the risk of 
cardiovascular disease (CVD) in patients with this eating 
disorder. 
Anorexia nervosa: Definitions, prevalence 
and prognosis
Anorexia nervosa (AN), according to the American 
Psychiatric Association (2000) and World Health 
Organization (1994), is diagnosed where there is evidence 
of low body weight and a refusal to maintain body weight 
within 85% of an age-predicted normal range accompa-
nied by an extreme fear of ‘fatness’, a distorted body image 
and menstrual dysfunction (cessation of at least three con-
secutive menstrual cycles). The low body weight is the 
consequence of self-induced weight loss mediated through 
severe caloric intake restriction. Individuals present with a 
very low body weight, low percentage of body fat, energy 
deficiency and menstrual dysfunction.
Signs and symptoms of AN include excessive exercising 
with low body weight, blood in vomit, inadequate fluid 
intake in combination with poor eating, and rapid weight 
loss (Treasure, 2004). Change in body mass index (BMI) is 
often used as a surrogate marker of AN risk, however, the 
utility of BMI as a diagnostic marker is limited for a 
number of reasons and it is recommended that BMI meas-
ures should be combined with an examination of resting 
heart rate, blood pressure, peripheral circulation, core 
temperature and muscle strength using the stand up/squat 
test (Treasure, 2004). For further information on this topic 
interested readers should visit www.eatingresearch.com. 
In young people, a BMI below the second percentile is 
often a useful diagnostic threshold—further information 
is available at www.cdc.gov/growthcharts.
AN is a potentially life-threatening eating disorder with 
the highest rates for premature mortality of any psychiat-
ric disorder in adults (Papadopoulos et al, 2009; Attia, 
2010). In the UK, prevalence data is sparse but it is esti-
mated 4 in 1000 females have AN, which equates to 
1.4   million females (National Institute of Health and 
Clinical Excellence (NICE), 2004). However this figure is 
considered somewhat conservative as it is based on pri-
mary care referral data and many individuals with eating 
disorders may either not seek medical advice or seek 
advice through private medical units (NICE, 2004). 
The prognosis for AN is poor with a six-fold increase 
in standard mortality rates compared with the general 
population (Papadopoulos et al, 2009). The longevity of 
the illness will also affect mortality risk. In the US, data 
collected by the Mayo Clinic between 1938 and 1984 
indicate a mortality rate of 5% when the sufferer has 
been diagnosed with AN for between 4 and 5 years, how-
ever, in enduring AN of 20–30 years, risk of sudden 
cardiac death (SCD) increases alarmingly to 15–20% 
(Lucas et al, 1991). 
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In young people, especially females, a high importance is placed on 
body image and physical appearance. Unfortunately, misperceptions 
of the ideal body shape can encourage a pre-occupation with weight 
loss strategies. Long-term, these strategies may lead to ill-health—
anorexia nervosa (AN) is a condition where there is evidence of low 
body weight, a refusal to maintain body weight, a distorted body 
image, and menstrual dysfunction. This review focuses on screening 
techniques for identifying cardiovascular risk in patients with AN. 
Predictors of cardiac risk have not been robustly investigated in AN, 
consequently health professionals involved in cardiovascular risk 
screening may be reliant on screening methodologies that are based 
on anecdotal evidence. The current inability to accurately predict 
cardiac events and sudden cardiac death in chronically ill patients 
with enduring AN is a concern that requires greater national attention
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Cardiovascular abnormalities in AN
In female patients diagnosed with AN, cardiovascular 
abnormalities are common and the risk of SCD is increased 
compared with healthy females (Casiero and Frishman, 
2006). The likelihood of cardiovascular problems depends 
on the severity and/or duration of energy restriction, the 
amount, rate, and composition of weight loss, and the 
degree of electrolyte imbalances (Beals, 2004). 
Studies show that cardiac complications, including 
electrocardiographic (ECG) abnormalities, reduced ven-
tricular mass, impaired myocardial performance, atrial 
and ventricular arrhythmias, myocardial infarction, peri-
cardial effusion and mitral regurgitation, are evident in 
up to 86% of AN patients (Krantz et al, 2005; Myslobodsky, 
2005; Olivares et al, 2005). In enduring AN, abnormal 
neuroendocrine responses also increase cardiovascular 
risk. Low levels of leptin and insulin, and elevated levels 
of ghrelin and possibly adiponectin have been observed 
(Misra and Klibanski, 2010) in conjunction with adverse 
lipid profiles (Friday et al, 1993; De Souza and Williams, 
2004) and endothelial dysfunction (Zeni-Hoch et al, 
20030; Ricklund et al, 2005). The negative physiological 
effects on the cardiovascular system are thought, partially, 
to be a result of hypothalamic hypoestrogenism (low oes-
trogen levels). 
Rapid weight loss in patients with AN leads to a marked 
loss of skeletal muscle tissue, which is complicated by elec-
trolyte imbalances often caused by habitual use of diuret-
ics, emetics, and laxatives that can potentially lead to 
arrhythmias and ultimately SCD (Nudel et al, 1984). In 
AN, arrhythmias often manifest as acute bradycardia and 
may occur as a consequence of the body’s attempt to con-
serve energy by reducing cardiac output (Vazquez et al, 
2003). Several different pathological mechanisms have 
been proposed, including electrolyte loss, interstitial oede-
ma, reduction in the glycogen content of the myocardium, 
and myofibrillar atrophy, which have been demonstrated 
in rat models (Clark and Wildenthal, 1986; Tolnai and von 
Althen, 1987).
Electrical and structural cardiac abnormalities 
in AN 
The precise characterization of heart rate dynamics may 
have important clinical implications (Vigo et al, 2008). 
Many female AN patients will have significantly increased 
QT intervals compared with healthy females of the same 
age. The QT interval represents the time delay between the 
start of the Q wave and the end of the T wave and is 
known as the QTc interval when corrected for heart rate. 
QTc interval is often considered to be increased if it is 
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greater than 440 milliseconds (Vasquez et al, 2003). 
The value of a prolonged QT dispersion (QTd) for pre-
dicting severe ventricular arrhythmias and SCD are well 
established (Swenne and Larsen, 1999). The QTd interval 
is the difference between the maximum and the minimum 
QTc intervals measured in the 12 leads, cut-off values 
around 60  milliseconds have been reported (Toivonen, 
2002), and this marker may be used as a predictor of 
cardio vascular risk in patients with AN. 
Furthermore, the measurement of heart rate variability 
(HRV) may also be useful in AN patients as increased QT 
interval variability is associated with serious cardiac 
arrhythmias in this population (Koschke et al, 2009). HRV 
reflects the variability in the time intervals between con-
secutive heart beats and indicates the balance in the auto-
nomic nervous system as a consequence of sympathetic/
parasympathetic activity. Ishizawa et al (2008) reported 
that 32 AN patients had reduced sympathetic responsive-
ness and increased parasympathetic responsiveness com-
pared with 37 healthy controls following a period of rest in 
the supine position. HRV appears to be abnormal in AN 
patients compared with healthy controls (Kriepe et al, 
1994; Petretta et al, 1997; Casu et al, 2002; Melanson et al, 
2004). 
Structural cardiac abnormalities are also evident in AN 
patients as cardiac chamber size and left ventricular mass 
are reduced compared with healthy aged-matched con-
trols, in absolute terms and after adjustment for body mass 
(Vazquez et al, 2003), which may relate to the consequenc-
es of longstanding hypovolemia (Casiero and Frishman, 
2006). Consequently, cardiac output is reduced and 
peripheral vascular resistance increases despite the pres-
ence of hypotension. 
Vazquez et al (2003) also suggested that the reduction in 
left ventricular mass may be responsible for the increase in 
QT interval dispersion in AN patients, which in turn may 
be explained by alterations in cardiac muscle fibres and in 
the function of potassium channels in the hypotrophied 
cardiac myocytes. 
Cardiovascular risk factors in AN
Evaluation of traditional risk factors is an important first 
step in the identification of individuals with AN who are at 
risk of developing CVD. Novel blood biomarkers relevant 
to the pathophysiology of atherothrombosis—for example, 
inflammatory response markers, coagulation markers, 
platelet aggregation markers, and markers of lipoprotein or 
lipid-related variables—have been proposed in the assess-
ment of atherosclerotic progression (Koenig, 2007). In 
addition, the development of non-invasive procedures to 
evaluate cardiovascular vessel structure and function is 
becoming increasingly important (Cohn et al, 2009). 
However, we need to consider whether these contempo-
rary risk factors are relevant to the AN population who are 
traditionally young with low body weight and have a low 
dietary fat intake. Hypothalamic amenorrhoea (HA), the 
consequence of severe caloric restriction and oestrogen 
deficiency, is a significant risk factor in patients with long-
term AN, carrying a heavy burden of physical morbidity 
and cardiovascular mortality (Casiero and Frishman, 2006; 
Lawson et al, 2007; Attia, 2010). HA is a reversible disorder 
that results in cessation of the menses (Marcus et al, 2001). 
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Rapid weight loss in patients with anorexia nervosa leads to a marked loss of skeletal muscle tissue
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HA displays a strong interaction between psychological 
factors and endocrine function (Giles and Berga, 1993). 
Individuals with eating disorder symptoms, poor coping 
mechanisms, and mood disorders are all susceptible to HA. 
Studies have linked HA to impaired bone health and more 
recently to an altered cardiovascular phenotype, due to 
adaptations in vascular function and autonomic regulation 
(Zeni-Hoch et al, 2003; O’Donnell et al, 2009). 
Given the established link between low left ventricular 
ejection fraction (LVEF) and subsequent SCD in cardiac 
populations, echocardiographic measurements may also 
be important for risk prediction in the AN population 
(Shiga et al, 2009). It has been suggested that echocardio-
graphic assessment of cardiac structure and function and 
serum electrolyte measurements may enhance the prog-
nostic outcome of HRV studies (Vigo et al, 2008). 
Echocardiography and the biomarker B-type natriuretic 
peptide (BNP) appear to provide a powerful incremental 
assessment of cardiac function, clinical status, and out-
come across the spectrum of cardiac disease and there is 
strong evidence to support their integrated use in the 
diagnosis and management of cardiovascular disease 
(Misra et al, 2004; Troughton and Richards, 2009). 
However, supportive evidence is sparse in the AN popula-
tion and more research is required, which may allow a 
more targeted screening algorithm to be developed. 
The use of novel serum biomarkers that are predictive of 
premature CVD risk may also be important in AN patients. 
The ideal risk marker would be one that provides detailed 
and reliable prognostic information with sufficient sensitiv-
ity and specificity to direct specific interventions that 
improve outcomes, while remaining inexpensive, simple to 
interpret, safe to obtain and readily accessible in a broad 
range of health-care environments (Rosenbaum, 2008). 
Clearly further research is required to develop effective and 
inexpensive biomarkers for assessing CVD risk in AN.
As a consequence of a long-term loss of lean tissue, 
patients with enduring AN will lose oestrogen and there-
fore the regularity of the menstrual cycle is affected 
(Leung et al, 2004). Despite the prescription of oral oestro-
gen to offset the risk of amenorrhea, cardiovascular risk 
remains elevated as oral oestrogen adversely raises levels 
of high-sensitivity C-reactive protein (hs-CRP), a potent 
inflammatory risk marker for CVD (Leung et al, 2004; 
Lawson, et al, 2007). Lawson and colleagues (2007) 
reported that in females with AN who were prescribed 
oestrogen-based oral contraceptive pills, there was a 
greater than 20% likelihood of having higher risk hs-CRP 
levels (>3 mg/litre). The authors suggested that the accom-
panying raised interleukin-6 (IL-6) response in these 
participants may indicate an increased systemic inflam-
matory influence on hs-CRP levels. This observation rais-
es the possibility that elevated hs-CRP levels in young 
females with AN could be predictive of future cardiac 
events, particularly if a higher than normal hs-CRP level is 
chronically sustained. 
Screening AN patients for CVD risk has traditionally 
focused on physical/physiological factors. However, some 
psychological conditions also carry a CVD risk burden. 
Depression and anxiety have previously been associated 
with increased cardiac morbidity and mortality in clinical 
and healthy populations (Barth et al, 2004; Frasure-Smith 
and Lespé, 2008). Further, links between an elevated risk 
for cardiac events and the ‘distressed’ type-D personality, 
characterized by negative affectivity and social inhibition, 
have been made. 
Investigation Threshold of consideration Threshold of action
Body mass index (kg/m2) <14 <12
Weight loss/week (kg) >0.5 >1.0
Temperature °C <35 <34.5
Blood pressure (mmHg) <90/<70 <80/<60
Heart rate (bpm) <50 <40
Haemoglobin (g/dl) <11.0 <9.0
Potassium (mmol/litre) <3.5 <3.0
Sodium (mmol/litre) <135 <130
Urea (mmol/litre) >7 >10
Corrected QT interval (QTc; milliseconds) >450*
*Note that ECG is recommended in all AN patients if BMI is <14 kg/m2 and if drugs that may effect ECG trace are 
prescribed 
If a patient’s health status falls into the ‘threshold of consideration’ then weekly reviews of his/her status are 
recommended, which may include urgent referral to an eating disorders specialist. If a patient’s health status falls into the 
‘threshold of action’ then immediate contact and referral to an eating disorders clinic is necessary. Urgent medical 
attention is required
Adapted from Treasure 2004
Table 1. 
Current CVD risk algorithm in patients with anorexia nervosa
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Denollet (2005) suggested that an examination of acute 
(such as current stress) and long-term (such as type-D 
personality) psychological factors may be useful in identi-
fying high-risk candidates for cardiac events or SCD. It 
has been speculated that elevated cortisol (a stress hor-
mone) may be the mediating factor in the association 
between type-D personality and an increased risk of CVD 
(Sher, 2005) although further research is required. It is 
possible that there is a higher prevalence of type-D per-
sonality in AN patients, however, further research is 
required to confirm this assertion. 
Routine screening investigations
In order to identify the severity of CVD risk in AN 
patients a screening pathway was proposed by Treasure 
(2004). For the purposes of this article we have adapted 
the content to focus specifically on CVD risk (Table 1), 
however, the original paper focused on global medical risk 
in AN patients. We would suggest that this should be used 
as a good starting point and propose that further research 
be undertaken that is focused on optimizing the screening 
protocol for CVD risk in AN patients. 
Conclusions
Predictors of cardiac risk have not been robustly investi-
gated in AN, consequently health professionals involved 
in CV risk screening and prevention may be reliant on 
screening methodologies that are based on anecdotal evi-
dence. It is not surprising that in primary care, SCD detec-
tion rates in AN patients is low. The current inability to 
accurately predict cardiac events and SCD in chronically 
ill patients with AN is a concern that requires greater 
national attention. 
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Key Points
 w Anorexia nervosa (AN) is a condition where there is evidence of low 
body weight, a refusal to maintain body weight, an extreme fear of 
‘fatness’, and a distorted body image, and menstrual dysfunction
 w AN is a potentially life-threatening eating disorder with the highest 
rates for premature mortality of any psychiatric disorder in adults 
 w In the UK, prevalence data is conservatively estimated to be 4 per 
1000 females which equates to around 1.4 million females
 w The prognosis for AN is poor with a six-fold increase in the standard 
mortality rates compared with the general population
 w Poor prognosis is strongly associated with increased cardiac risk in 
AN patients
 w More robust screening modalities for identifying CV risk are required 
to assist health professionals involved in cardiovascular risk 
screening and prevention in early detection, diagnosis and 
management of sudden cardiac death risk in AN
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